Anesthetic management of the EXIT (ex utero intrapartum treatment) procedure

• Published in: Journal of clinical anesthesia Vol. 13; no. 5; pp. 387 - 391
• Main Authors: SCHWARTZ, Donald A, MORIARTY, Kevin P, TASHJIAN, David B, WOOL, Robert S, PARKER, Robert K, MARKENSON, Glenn R, ROTHSTEIN, Robert W, SHAH, Bhavash L, CONNELLY, Neil Roy, COURTNEY, Richard A
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Science 01.08.2001
• Subjects: Abdominal surgery. Urology. Gynecology. Obstetrics; Adult; Airway Obstruction - congenital; Airway Obstruction - etiology; Airway Obstruction - surgery; Anesthesia; Anesthesia depending on type of surgery; Anesthesia, Obstetrical; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Biological and medical sciences; Cysts - complications; Cysts - congenital; Cysts - surgery; Female; Fetal Monitoring; Fetus - blood supply; Humans; Infant, Newborn; Medical sciences; Monitoring, Intraoperative; Mouth Diseases - complications; Mouth Diseases - congenital; Mouth Diseases - surgery; Placenta - blood supply; Pregnancy; Regional Blood Flow - physiology; Ultrasonography, Prenatal; Volatile compound; Human; Tongue; Respiratory disease; General anesthesia; Obstruction; Case study; Sevoflurane; Respiratory tract; Fetal diseases; General anesthetic; Surgery; Cyst; Female; Fetus; Oral cavity disease; Benign neoplasm; Delivery; Cesarean section; Monitoring; Halogen Organic compounds

The EXIT (ex utero intrapartum treatment) procedure is used to maintain fetal-placental circulation during partial delivery of a fetus with a potentially life-threatening upper airway obstruction. We performed the EXIT procedure on a fetus with a large intra-oral cyst. Sevoflurane was used as the an...